Wegovy pill interactions: levothyroxine, insulin, birth control and alcohol
Wegovy pill interactions start with timing: the tablet needs 30 minutes alone before any other oral medicine. The label flags insulin and sulfonylureas for low blood sugar and reports 33% higher thyroxine exposure with levothyroxine. Metformin, birth-control pills, warfarin and statins showed no clinically significant change. Other semaglutide or GLP-1 products should not be combined.
Interactions at a glance
| Substance | Level | What happens | What to do |
|---|---|---|---|
| Other semaglutide (Ozempic, Rybelsus, Wegovy pen, compounded semaglutide) | avoid | The label's Limitations of Use say Wegovy should not be used with other semaglutide-containing products. | Do not take them together. If you are moving from one to another, ask your prescriber for the exact stop and start dates. |
| Other GLP-1 medicines (Zepbound, Mounjaro, Foundayo, Trulicity, Saxenda) | avoid | Combining Wegovy with any other GLP-1 receptor agonist is not recommended in the label. | Treat any change as a switch, not an add-on, and plan it with your prescriber. |
| Insulin | use with caution | Higher risk of low blood sugar, including severe episodes. The label notes Wegovy with insulin has not been evaluated. | Ask whether your insulin dose should be reduced when starting, and check glucose before and during treatment as the label advises. |
| Sulfonylureas (glipizide, glimepiride, glyburide) | use with caution | As insulin secretagogues, they raise the risk of hypoglycemia with semaglutide (label 5.4, 7.1). | Ask your prescriber whether the sulfonylurea dose should come down when the Wegovy pill starts. |
| Levothyroxine | monitor | A label study measured 33% more total thyroxine exposure (AUC) after levothyroxine with oral semaglutide; the peak level did not change. | Ask whether your thyroid levels should be rechecked after starting, and agree the morning order of the two tablets. |
| Warfarin | monitor | No clinically significant change in S- or R-warfarin exposure in the label's study, but warfarin has a narrow therapeutic index. | Ask whether an extra INR check is sensible after starting, in line with the label's advice on narrow-index drugs. |
| Digoxin | monitor | No clinically significant pharmacokinetic change in the label's study; digoxin is another narrow-therapeutic-index drug. | Mention it to your prescriber, who may choose closer monitoring. |
| Other daily oral medicines, vitamins and supplements | use with caution | Anything taken within 30 minutes can reduce semaglutide absorption, and slower stomach emptying may change how other drugs are absorbed. | Take them after the 30-minute wait, and ask which of yours need closer monitoring. |
| Metformin | no known interaction | No clinically significant change in metformin pharmacokinetics with semaglutide (label 12.3). | No change is needed on interaction grounds; take metformin after the 30-minute window. |
| Birth-control pills (ethinyl estradiol, levonorgestrel) | no known interaction | No clinically significant pharmacokinetic differences with semaglutide in the label's study. | Continue as prescribed. Ask your prescriber about backup methods if vomiting happens close to your pill time. |
| Lisinopril, furosemide, rosuvastatin | no known interaction | Each was studied with semaglutide, with no clinically significant pharmacokinetic differences (label 12.3). | No interaction step needed. Tell your prescriber about ongoing vomiting or diarrhea, which the label links to dehydration and kidney injury. |
| Omeprazole and other acid reducers | no known interaction | Omeprazole did not change semaglutide pharmacokinetics in a clinically significant way (label 12.3). | Take it after the 30-minute wait, like any other oral medicine. |
| Alcohol | use with caution | The label does not address alcohol. With insulin or a sulfonylurea, alcohol can cause low blood sugar (ADA). Heavy drinking is a common cause of pancreatitis (NIDDK). | Never take the tablet with alcohol, and agree a safe limit with your prescriber. |
| General anesthesia or deep sedation | use with caution | Delayed stomach emptying can leave food in the stomach; the label reports rare aspiration cases with GLP-1 medicines. | Tell the surgical or endoscopy team you take the Wegovy pill well before the date. |
With metformin
Metformin and the Wegovy pill can be taken by the same person. The label's interaction studies found no clinically significant change in metformin's pharmacokinetics alongside semaglutide (section 12.3). Metformin is not on the label's list of drugs that raise hypoglycemia risk with Wegovy, which names insulin and insulin secretagogues such as sulfonylureas.
Two practical points. First, timing: metformin is an oral medicine, so it waits until 30 minutes after the Wegovy tablet. Second, if you take metformin for type 2 diabetes, note that the tablets' weight trial excluded type 2 diabetes, and average semaglutide levels in people with diabetes ran lower than on the injection. Ask your prescriber how they will judge whether the pill is working for you.
Insulin and other diabetes medicines
Semaglutide lowers blood glucose, and the label warns that the risk of hypoglycemia rises when it is combined with insulin or an insulin secretagogue such as a sulfonylurea (sections 5.4 and 7.1). It advises considering a lower dose of those medicines when Wegovy starts, and checking blood glucose before and during treatment in anyone with diabetes. Wegovy with insulin has not been evaluated.
For scale: in a weight trial of the 2.4 mg injection in type 2 diabetes, clinically significant lows below 54 mg/dL occurred in 6.2% on semaglutide against 2.5% on placebo. In a trial of 9 mg and 25 mg tablets in type 2 diabetes without insulin, rates were similar between the doses. Learn the signs from the Medication Guide: shakiness, sweating, hunger, confusion and a fast heartbeat.
Medicines taken by mouth
Oral medicines interact with the Wegovy pill in two ways. The first is the 30-minute rule: the label says to wait at least 30 minutes after the tablet before eating, drinking or taking other oral medicines, because semaglutide absorption improved with longer post-dose fasting.
The second is slower stomach emptying, which can change how other drugs are absorbed. The label's tablet studies are reassuring for most: lisinopril, warfarin, metformin, digoxin, ethinyl estradiol, levonorgestrel, furosemide and rosuvastatin showed no clinically significant changes. Levothyroxine was the exception: a single 600 mcg dose produced 33% more total thyroxine exposure, so thyroid tests may be repeated. For any drug with a narrow therapeutic index, the label advises extra clinical or laboratory monitoring.
Alcohol
The Wegovy label sets no rule on alcohol, but two cautions from other authorities apply. According to the American Diabetes Association, drinking while on insulin or a sulfonylurea can push glucose too low, and the drop can arrive hours later, particularly if you drank without eating. NIDDK lists heavy alcohol use among the most common causes of pancreatitis, a condition the Wegovy label already warns about.
The tablet itself must only ever go down with plain water, so a morning drink is never part of the dose. The ADA's definition of moderate intake is no more than one drink daily for women and two for men; whether that fits you on Wegovy is a question for your prescriber, especially if you also take a glucose-lowering medicine.
Supplements and food
Food is the interaction that matters most for this tablet. It goes in on an empty stomach, and nothing else, coffee and breakfast included, goes in for at least 30 minutes. Vitamins and supplements count as oral medicines and wait too; the Medication Guide asks you to list them for your prescriber. Semaglutide is broken down by protein cleavage rather than by liver CYP enzymes, and the label says it has very low potential to inhibit or induce those enzymes, so CYP-related warnings such as grapefruit are not expected to apply.
Before surgery or a procedure
The Wegovy label warns of rare pulmonary aspiration during general anesthesia or deep sedation in people taking GLP-1 medicines, and says the data are too limited to show whether holding the drug helps. Joint guidance published in October 2024 by the American Society of Anesthesiologists and four other societies concludes that GLP-1 treatment can usually carry on before elective procedures. For higher-risk patients, such as those in the dose-escalation phase or on higher doses, it suggests a 24-hour liquid diet beforehand, and people with GI symptoms such as nausea or vomiting should have elective procedures delayed. Tell every procedural team you take the Wegovy pill.
Frequently asked questions
Can I take levothyroxine and the Wegovy pill in the same morning?
Yes, but both want an empty stomach, so the order needs agreeing with your prescriber. Under the label, the semaglutide tablet goes first, then 30 minutes pass before levothyroxine or any other pill. One label study found total thyroxine exposure 33% higher when the two were given together, so your thyroid levels may be rechecked. Ask: "When should my thyroid levels be checked after I start?"
Does the Wegovy pill make birth control pills less effective?
The label's interaction study found no clinically significant change in ethinyl estradiol or levonorgestrel exposure with semaglutide, and the Wegovy label carries no backup-contraception advice. Vomiting is a separate issue: if you are sick soon after a contraceptive pill, ask your prescriber or pharmacist what to do. Also note the label advises stopping Wegovy at least 2 months before a planned pregnancy.
Can I take ibuprofen or Tylenol with the Wegovy pill?
The Wegovy label does not list ibuprofen or acetaminophen as interacting drugs, and neither appears among its studied combinations. The general rules still apply: take them after the 30-minute window, not with the Wegovy tablet. Severe or persistent abdominal pain is a reason to call your prescriber rather than reach for a painkiller, because the label lists pancreatitis and gallbladder disease as possible causes.
Can I take the Wegovy pill with Ozempic or Rybelsus?
No. All three contain semaglutide, and the Wegovy label recommends against pairing it with another semaglutide product or with a second GLP-1 receptor agonist. Someone moving from Ozempic or Rybelsus to the Wegovy pill needs a planned switch with stop and start dates from their prescriber; the label gives exact switching rules only between the Wegovy injection and Wegovy tablets.
Do I need to stop the Wegovy pill before a colonoscopy?
Not automatically. Under the October 2024 joint anesthesia and gastroenterology guidance, GLP-1 treatment usually continues, with a 24-hour liquid diet suggested for higher-risk patients such as those still titrating, and a delay for anyone with active GI symptoms. The Wegovy label asks you to tell providers before any procedure. Ask the endoscopy team for their instructions for the day before and the morning of.
Sources
- Wegovy (semaglutide) injection and tablets prescribing information and Medication Guide, NDA 218316/S-005, revised 03/2026, FDA (sections 1, 5, 7, 12.3) (checked October 5, 2026)
- New multi-society GLP-1 clinical practice guidance, American Society of Anesthesiologists news release, 29 October 2024 (checked October 5, 2026)
- Alcohol and diabetes, American Diabetes Association (checked October 5, 2026)
- Symptoms and causes of pancreatitis, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (checked October 5, 2026)
Compounded semaglutide and compounded tirzepatide are not FDA-approved generics of the brand-name products. A licensed 503A compounding pharmacy prepares each one for a single prescription.
Get started
Start online, and a licensed physician reviews your request
A short online questionnaire is the first step. No appointments and no insurance needed.
A licensed physician reviews every request. Nothing on this page is a prescription.